SEC Form D filing

Electra Therapeutics, Inc., 2025-10-30

An SEC Form D private-offering notice from South San Francisco, CA, a $184,133,425 filer-stated offering target in Biotech. Filed 2025-10-30. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Electra Therapeutics, Inc. site↗ Verified via SEC Form D

Develops SIRP directed antibody therapies targeting immunological diseases and cancer, lead candidate ELA026 in clinical development for sHLH.

Filed 2025-10-30Filed to raise $184,133,425First money in 2025-10-15Raised so far $134,188,389HQ (as filed) South San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified electra-therapeutics.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source